Engineering novel bio-inspired materials for stem-cell mediated bone regeneration
工程新型仿生材料用于干细胞介导的骨再生
基本信息
- 批准号:8632328
- 负责人:
- 金额:$ 45.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-03-14 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAnimal ModelAppearanceAreaAutologous TransplantationBehaviorBindingBiochemicalBiocompatible MaterialsBiologicalBiological AssayBiological ProcessBiomechanicsBone Marrow Stem CellBone RegenerationBone SurfaceBone TissueBone TransplantationBromodeoxyuridineCalciumCalvariaCarbonatesCatecholaminesCell Culture TechniquesCell ProliferationCell TherapyCephalicCeramicsCollagenCompressive StrengthDataDefectDeformityDentalDevelopmentDopamineDopamine ReceptorDoseDrug FormulationsEngineeringExtracellular MatrixGelatinGene ExpressionGoalsGrowthHealedHealthHigh Pressure Liquid ChromatographyHydroxyapatitesImpairmentIn VitroInheritedKineticsLigandsMaterials TestingMeasurementMechanicsMediatingMesenchymal Stem CellsMineralsMissionModelingMoldsMolecular StructureNatural regenerationOperative Surgical ProceduresOralOsseointegrationOsteoblastsOsteogenesisPathway interactionsPatientsPerformancePhosphate BufferPolymersProductionPropertyPublic HealthQuality of lifeRattusResearchSideSignal TransductionSilanesSiloxanesSmall Interfering RNASolutionsStaining methodStainsStem cellsStimulusStressTdT-Mediated dUTP Nick End Labeling AssayTensile StrengthTestingTimeTissue EngineeringTransplanted tissueTraumaWeight-Bearing stateadhesive protein (mussel)biodegradable polymerbonebone cellbone healingcopolymercraniofacialcrosslinkdentofacialdesigndopamine graftface bone structurehealingimprovedin vivointerfacialmeetingsmineralizationnanocompositenanocrystalnovelphysical propertypublic health relevancereceptorrepairedscaffoldself organizationsilaneskeletal
项目摘要
A synthetic biomaterial that mimics the mechanical strength, resorbability, and composition of natural bone
hydroxyapatite (HAP) and collagen is not currently available. Synthetic grafts compromising properties
between initial strength and resorbability are not ideal for repairing critical sized defects. Thus, large bone
defects are not well addressed with current synthetic materials leading to significant impairments of biological
function, appearance, and patient quality of life. This project proposes to develop a rigid, bio-inspired material
using principles of 1) self-organization of HAP nanocrystals in gelatin molecule and 2) pH-induced calcium-
ligand cross-links inspired from the mussel adhesive protein - dopamine.
Strong pilot data support all of the proposed aims. Our polydopamine laced HAP-gelatin nanocomposite
(PDHG) has compressive and tensile strength approximating 90% and 60% of cortical bone, respectively, and
is degradable in vitro. We believe that incorporation of a dopamine-grafted long chain polymer can further
improve tensile strength and portends the Long Chain enhanced PDHG (LcPDHG) porous scaffold applicable
for CSD repair. The dopamine released from the scaffold also produces positive effects on osteogenesis. The
long-term goal of this team is to engineer LcPDHG to fulfill the initial biomechanical requirements and to be
eventually resorbed and replaced by endogenous bone. The objective in this particular application is to identify
how the incorporation of long chain polymers affects the physical properties (e.g., tensile strength,
degradation) of LcPDHG, and how the natural bone and stem cells respond to free dopamine released from
LcPDHG.
The central hypothesis is that the LcPDHG is a bioactive material with adequate mechanical strength,
osteoconductivity and resorption potential to serve as a load bearing graft in CSDs in craniofacial and other
skeletal areas. To test this hypothesis three specific aims are proposed: (1) Elucidate the mechanism by which
LcPDHG enhances mechanical properties of PDHG to approximate natural bone, and increases its in vitro
degradation; (2) Determine cellular mechanisms by which dopamine promotes bone regeneration in the
LcPDHG scaffold; and (3) Assess bone formation and replacement of graft materials in LcPDHG scaffolds in a
rat calvarial critical sized defect model. Preliminary data predict promising interactions between osteoblasts
and dopamine stimuli, and suggest novel signaling via dopamine receptors to promote stem cell-based
therapy.
The proposed research is significant because it will advance and expand the understanding of how
dopamine can be used in bone tissue engineering (TE) and provide the first "hydroxyapatite and collagenous"
artificial bone TE scaffold to repair large bone defects. With a graft material of this type, it should be possible to
eliminate multiple surgeries and simplify the treatment of critical-size cranial and facial bone defects.
一种合成生物材料,模仿天然骨的机械强度,可吸收性和组成
目前尚不可用羟基磷灰石(HAP)和胶原蛋白。合成移植物损害特性
初始强度和可吸收性之间并不是修复关键尺寸缺陷的理想选择。因此,大骨头
当前合成材料无法很好地解决缺陷,从而导致生物学的重大损害
功能,外观和患者生活质量。该项目建议开发一种僵化的生物启发材料
使用1)明胶分子中HAP纳米晶体的自组织和2)pH诱导的钙 -
贻贝粘合剂蛋白 - 多巴胺启发的配体交联。
强大的飞行员数据支持所有拟议的目标。我们的多巴胺系带HAP明星蛋白纳米复合材料
(PDHG)分别具有约90%和60%皮质骨的压缩和拉伸强度,并且
在体外可降解。我们认为,掺入多巴胺的长链聚合物可以进一步
提高拉伸强度并预示长链增强PDHG(LCPDHG)的多孔脚手架
用于CSD维修。从支架释放的多巴胺也会对成骨作用产生积极影响。这
该团队的长期目标是设计LCPDHG,以满足最初的生物力学要求,并将
最终被内源性骨头吸收并取代。该特定应用程序的目的是确定
长链聚合物的掺入如何影响物理特性(例如,拉伸强度,
LCPDHG的降解),以及天然骨骼和干细胞如何反应自由的多巴胺从
lcpdhg。
中心假设是LCPDHG是一种具有足够机械强度的生物活性材料,
在颅面和其他的CSD中充当CSD的载荷移植物的破骨接球率和吸收潜力
骨骼区域。为了检验该假设,提出了三个具体目标:(1)阐明该机制
LCPDHG增强了PDHG的机械性能近似于天然骨骼,并增加了其体外
降解; (2)确定多巴胺促进骨再生的细胞机制
lcpdhg脚手架; (3)评估在A中的LCPDHG支架中的骨形成和替代移植物材料
大鼠颅关临界大小缺陷模型。初步数据预测成骨细胞之间有希望的相互作用
和多巴胺刺激,并通过多巴胺受体提出新的信号传导,以促进基于干细胞
治疗。
拟议的研究很重要,因为它将提高和扩大对如何的理解
多巴胺可用于骨组织工程(TE),并提供第一个“羟基磷灰石和胶原蛋白”
人造骨支架可修复大骨缺损。使用这种类型的移植物材料,应该有可能
消除多次手术,并简化临界大小的颅骨和面部骨缺损的处理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ching-Chang Ko其他文献
Ching-Chang Ko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ching-Chang Ko', 18)}}的其他基金
Engineering novel bio-inspired materials for stem-cell mediated bone regeneration
工程新型仿生材料用于干细胞介导的骨再生
- 批准号:
9012688 - 财政年份:2014
- 资助金额:
$ 45.71万 - 项目类别:
Engineering novel bio-inspired materials for stem-cell mediated bone regeneration
工程新型仿生材料用于干细胞介导的骨再生
- 批准号:
9229019 - 财政年份:2014
- 资助金额:
$ 45.71万 - 项目类别:
Engineering a new biomaterial for stem-cell mediated bone regeneration
设计用于干细胞介导的骨再生的新型生物材料
- 批准号:
7531860 - 财政年份:2008
- 资助金额:
$ 45.71万 - 项目类别:
Engineering a new biomaterial for stem-cell mediated bone regeneration
设计用于干细胞介导的骨再生的新型生物材料
- 批准号:
7894708 - 财政年份:2008
- 资助金额:
$ 45.71万 - 项目类别:
Engineering a new biomaterial for stem-cell mediated bone regeneration
设计用于干细胞介导的骨再生的新型生物材料
- 批准号:
7666277 - 财政年份:2008
- 资助金额:
$ 45.71万 - 项目类别:
Engineering a new biomaterial for stem-cell mediated bone regeneration
设计用于干细胞介导的骨再生的新型生物材料
- 批准号:
8098914 - 财政年份:2008
- 资助金额:
$ 45.71万 - 项目类别:
相似国自然基金
肾—骨应答调控骨骼VDR/RXR对糖尿病肾病动物模型FGF23分泌的影响及中药的干预作用
- 批准号:82074395
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
基于细胞自噬调控的苦参碱对多囊肾小鼠动物模型肾囊肿形成的影响和机制研究
- 批准号:
- 批准年份:2019
- 资助金额:33 万元
- 项目类别:地区科学基金项目
NRSF表达水平对抑郁模型小鼠行为的影响及其分子机制研究
- 批准号:81801333
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
靶向诱导merlin/p53协同性亚细胞穿梭对听神经瘤在体生长的影响
- 批准号:81800898
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
伪狂犬病病毒激活三叉神经节细胞对其NF-кB和PI3K/Akt信号转导通路影响的分子机制研究
- 批准号:31860716
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 45.71万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 45.71万 - 项目类别:
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 45.71万 - 项目类别:
Mechanisms of Metal Ion Homeostasis of Oral Streptococci
口腔链球菌金属离子稳态机制
- 批准号:
10680956 - 财政年份:2023
- 资助金额:
$ 45.71万 - 项目类别:
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
- 批准号:
10702126 - 财政年份:2023
- 资助金额:
$ 45.71万 - 项目类别: